The role of commensal organisms as pro-infectious agents in Staphylococcus aureus infection dynamics.
共生生物作为促感染剂在金黄色葡萄球菌感染动态中的作用。
基本信息
- 批准号:MR/R001111/1
- 负责人:
- 金额:$ 89.6万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Staphylococcus aureus is an important human pathogen that causes significant death and disease around the world. The problem is exacerbated by the spread of antibiotic resistant strains such as Methicillin Resistant S. aureus (MRSA). MRSA is generally a hospital-associated infection but recently community acquired MRSA has increased in the apparent absence of antibiotic selection. Thus there is a constant need to develop new control regimes for S. aureus, as this organism has begun to show resistance even to new antibiotics such as linezolid and no vaccine is available. To win this battle we must not only produce new treatments and preventative measures but also to understand the complexities of how S. aureus causes disease and thus how interventions can be best utilised, to reduce the disease burden and to minimise the development and spread of resistance to antibiotics. How do humans get infected with S. aureus? We have made the astonishing discovery that relatively harmless skin organisms and even their component cell walls are able to cause significant exacerbation of S. aureus infection, allowing disease to occur with a hugely reduced infectious dose. The most common route of human infection is via a wound and of course this will occur with whatever material gets in, including S. aureus. We have named the material that can augment S. aureus infection as "pro-infectious agents". We have opened a window on natural infection and in doing so provide novel avenues for trying to understand disease and how we may prevent it. The current application takes an interdisciplinary approach to understand how infection is initiated, the nature of material and organisms that can act as pro-infectious agents, how infection progresses and how such knowledge may be utilized to prevent and/or cure disease. Our background work and that proposed necessitates an integrated team led by a microbiologist and a clinician with research expertise in innate immunity. This combined expertise, coupled with important partners around the world, provides a proven network to underpin our ambitious proposal.Our work is underpinned by the use of animal models of infection, as this complex process cannot be recapitulated in vitro without understanding of what happens in vivo. We have uniquely developed the vertebrate zebrafish embryo as a model of S. aureus systemic disease. This provides a high-throughput, genetically tractable system where host:pathogen interaction can be observed in a living host. The importance of this model is that it has not only provided important insights into pathogenesis but has also informed our use of a mammalian system thus replacing many mouse experiments directly, reducing the numbers of mammals used and refining our approach. We will use a combination of animal models, together with in vitro analysis to determine the breadth of material that can augment S. aureus infection and the cellular and molecular mechanisms underlying this effect. Infection will then be mapped from initiation to endpoint in order to identify bottlenecks as sites for the development on novel intervention strategies. We will use a variety of approaches including state-of-the-art intravital microscopy in all models to determine the pathway of infection.The application provides an integrated package that will further our understanding of disease mechanisms and how this information may be used to inform clinical practice.
金黄色葡萄球菌是一种重要的人类病原体,在世界各地引起重大死亡和疾病。耐甲氧西林沙门氏菌等耐抗生素菌株的传播加剧了这一问题。金黄色葡萄球菌(MRSA)。MRSA通常是一种医院相关感染,但最近社区获得性MRSA在明显缺乏抗生素选择的情况下有所增加。因此,有一个不断的需要,以发展新的控制制度,S。金黄色葡萄球菌,因为这种微生物已经开始显示耐药性,甚至对新的抗生素,如利奈唑胺和没有疫苗可用。为了赢得这场战斗,我们不仅要开发新的治疗方法和预防措施,还要了解S。金黄色葡萄球菌引起疾病,因此如何最好地利用干预措施,以减少疾病负担,并尽量减少对抗生素耐药性的发展和传播。人类是如何感染S.金黄色?我们有一个惊人的发现,相对无害的皮肤微生物,甚至它们的细胞壁成分,都能引起沙门氏菌的严重恶化。金黄色葡萄球菌感染,使疾病发生的感染剂量大大减少。人类感染的最常见途径是通过伤口,当然,这将发生与任何材料进入,包括S。金黄色。我们已经命名了能增加S的物质。金黄色葡萄球菌感染作为“促感染剂”。我们打开了一扇关于自然感染的窗口,从而为尝试了解疾病以及如何预防疾病提供了新的途径。当前的应用采用跨学科的方法来了解感染是如何发起的、可以充当促感染因子的材料和生物体的性质、感染如何进展以及如何利用这些知识来预防和/或治疗疾病。我们的背景工作和建议需要一个由微生物学家和具有先天免疫研究专长的临床医生领导的综合团队。我们的专业知识与世界各地的重要合作伙伴相结合,为我们雄心勃勃的计划提供了可靠的网络支持。我们的工作得到了动物感染模型的支持,因为如果不了解体内发生的情况,就无法在体外重现这一复杂的过程。我们已经独特地开发了脊椎动物斑马鱼胚胎作为S。金黄色葡萄球菌全身性疾病这提供了一种高通量、遗传上易处理的系统,其中可以在活宿主中观察到宿主:病原体相互作用。该模型的重要性在于,它不仅提供了对发病机制的重要见解,而且还为我们使用哺乳动物系统提供了信息,从而直接取代了许多小鼠实验,减少了使用的哺乳动物数量并改进了我们的方法。我们将使用动物模型的组合,以及体外分析,以确定可以增加S的材料的宽度。金黄色葡萄球菌感染和这种作用的细胞和分子机制。然后将绘制从感染开始到终点的感染图,以确定瓶颈,作为开发新干预策略的位点。我们将在所有模型中使用各种方法,包括最先进的活体显微镜,以确定感染途径。该应用程序提供了一个集成包,将进一步加深我们对疾病机制的理解,以及如何使用这些信息为临床实践提供信息。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Staphylococcus aureus cell wall structure and dynamics during host-pathogen interaction.
- DOI:10.1371/journal.ppat.1009468
- 发表时间:2021-03
- 期刊:
- 影响因子:6.7
- 作者:Sutton JAF;Carnell OT;Lafage L;Gray J;Biboy J;Gibson JF;Pollitt EJG;Tazoll SC;Turnbull W;Hajdamowicz NH;Salamaga B;Pidwill GR;Condliffe AM;Renshaw SA;Vollmer W;Foster SJ
- 通讯作者:Foster SJ
Human skin commensals augment Staphylococcus aureus pathogenesis.
- DOI:10.1038/s41564-018-0198-3
- 发表时间:2018-08
- 期刊:
- 影响因子:28.3
- 作者:Boldock E;Surewaard BGJ;Shamarina D;Na M;Fei Y;Ali A;Williams A;Pollitt EJG;Szkuta P;Morris P;Prajsnar TK;McCoy KD;Jin T;Dockrell DH;van Strijp JAG;Kubes P;Renshaw SA;Foster SJ
- 通讯作者:Foster SJ
Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and the action of bactericidal antibiotics.
- DOI:10.1073/pnas.2106022118
- 发表时间:2021-11-02
- 期刊:
- 影响因子:11.1
- 作者:Salamaga B;Kong L;Pasquina-Lemonche L;Lafage L;von Und Zur Muhlen M;Gibson JF;Grybchuk D;Tooke AK;Panchal V;Culp EJ;Tatham E;O'Kane ME;Catley TE;Renshaw SA;Wright GD;Plevka P;Bullough PA;Han A;Hobbs JK;Foster SJ
- 通讯作者:Foster SJ
Commensal bacteria augment Staphylococcus aureus infection by inactivation of phagocyte-derived reactive oxygen species.
- DOI:10.1371/journal.ppat.1009880
- 发表时间:2021-09
- 期刊:
- 影响因子:6.7
- 作者:Gibson JF;Pidwill GR;Carnell OT;Surewaard BGJ;Shamarina D;Sutton JAF;Jeffery C;Derré-Bobillot A;Archambaud C;Siggins MK;Pollitt EJG;Johnston SA;Serror P;Sriskandan S;Renshaw SA;Foster SJ
- 通讯作者:Foster SJ
The Role of Macrophages in Staphylococcus aureus Infection.
- DOI:10.3389/fimmu.2020.620339
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Pidwill GR;Gibson JF;Cole J;Renshaw SA;Foster SJ
- 通讯作者:Foster SJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon J. Foster其他文献
An exhaustive multiple knockout approach to understanding cell wall hydrolase function in emBacillus subtilis/em
一种详尽的多重基因敲除方法来理解枯草芽孢杆菌中细胞壁水解酶的功能
- DOI:
10.1128/mbio.01760-23 - 发表时间:
2023-09-22 - 期刊:
- 影响因子:4.700
- 作者:
Sean A. Wilson;Raveen K. J. Tank;Jamie K. Hobbs;Simon J. Foster;Ethan C. Garner - 通讯作者:
Ethan C. Garner
In situ visualization of Braun’s lipoprotein on E. coli sacculi
- DOI:
10.1126/sciadv.add865 - 发表时间:
2023 - 期刊:
- 影响因子:13.6
- 作者:
Qi Sheng;Meng-Yao Zhang;Si-Min Liu;Zhuo-Wei Chen;Pei-Ling Yang;Hong-Su Zhang;Meng-Yun Liu;Kang Li;Long-Sheng Zhao;Ning-Hua Liu;Lu-Ning Liu;Xiu-Lan Chen;Jamie K. Hobbs;Simon J. Foster;Yu-Zhong Zhang;Hai-Nan Su - 通讯作者:
Hai-Nan Su
PEPTIDOGLYCAN OF STAPHYLOCCUS AUREUS INDUCES ENHANCED LEVELS OF MATRIX METALLOPROTEINASE-9 IN HUMAN BLOOD ORIGINATING FROM NEUTROPHILS
金黄色葡萄球菌肽聚糖可提高源自中性粒细胞的人血中基质金属蛋白酶 9 的水平
- DOI:
10.1097/01.shk.0000174935.13786.6c - 发表时间:
2005 - 期刊:
- 影响因子:3.1
- 作者:
Y. Wang;A. Myhre;Solveig J Pettersen;M. Dahle;Simon J. Foster;C. Thiemermann;Kristin Bjørnland;Ansgar O. Aasen;Jacob E. Wang - 通讯作者:
Jacob E. Wang
Tetracycline and Oxacillin Act Synergistically on Biofilms and Display Increased Efficacy In Vivo Against Staphylococcus aureus
- DOI:
10.1007/s00284-024-03959-4 - 发表时间:
2024-11-06 - 期刊:
- 影响因子:2.600
- 作者:
Amy K. Tooke;Rebecca E. Hodges;Josie F. Pyrah;Kenneth W. Bayles;Stephen A. Renshaw;Simon J. Foster - 通讯作者:
Simon J. Foster
The identification of Staphylococcus aureus factors required for pathogenicity and growth in 1 human blood . 2 3
鉴定1人血液中金黄色葡萄球菌致病性和生长所需的因子。
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
John Connolly;E. Boldock;L. Prince;S. Renshaw;4. MoiraK;Whyte;Simon J. Foster - 通讯作者:
Simon J. Foster
Simon J. Foster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simon J. Foster', 18)}}的其他基金
Biomedical Catalyst – Staphylococcus aureus Vaccine
生物医学催化剂—金黄色葡萄球菌疫苗
- 批准号:
MC_PC_14090 - 财政年份:2013
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Super-resolution fluorescence atomic force (SURFACE) microscopy
超分辨率荧光原子力(表面)显微镜
- 批准号:
BB/I023518/1 - 财政年份:2011
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Development of a vaccine against Staphylococcus aureus based on novel targets
基于新靶点开发金黄色葡萄球菌疫苗
- 批准号:
G1000768/1 - 财政年份:2011
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Bacterial cell wall architecture and dynamics
细菌细胞壁结构和动力学
- 批准号:
BB/H011005/1 - 财政年份:2010
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
UK-BaCWAN2: Continuation and Expansion of UK-Bacterial Cell Wall Assembly Network
UK-BaCWAN2:UK-细菌细胞壁组装网络的延续和扩展
- 批准号:
G0701400/1 - 财政年份:2008
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Interaction of Staphylococcus aureus and humans: Iron regulated surface proteins and a novel host defence mechanism
金黄色葡萄球菌与人类的相互作用:铁调节的表面蛋白和新型宿主防御机制
- 批准号:
G0600801/1 - 财政年份:2007
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Novel targets for vaccine development and immunotherapy to combat Staphylococcus aureus and other pathogens
对抗金黄色葡萄球菌和其他病原体的疫苗开发和免疫疗法的新目标
- 批准号:
BB/D525748/1 - 财政年份:2006
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
Analysis of peptidoglycan architecture in Gram positive bacteria
革兰氏阳性菌肽聚糖结构分析
- 批准号:
BB/D007534/1 - 财政年份:2006
- 资助金额:
$ 89.6万 - 项目类别:
Research Grant
相似海外基金
Microbial regulation of intestinal tuft cell homeostasis
肠道簇细胞稳态的微生物调节
- 批准号:
10638381 - 财政年份:2023
- 资助金额:
$ 89.6万 - 项目类别:
The trigger and homeostatic function of a novel immune-sebum circuit
新型免疫皮脂回路的触发和稳态功能
- 批准号:
10662229 - 财政年份:2022
- 资助金额:
$ 89.6万 - 项目类别:
Immune interactions with commensal microbes in early life
生命早期与共生微生物的免疫相互作用
- 批准号:
10567936 - 财政年份:2022
- 资助金额:
$ 89.6万 - 项目类别:
The trigger and homeostatic function of a novel immune-sebum circuit
新型免疫皮脂回路的触发和稳态功能
- 批准号:
10464925 - 财政年份:2022
- 资助金额:
$ 89.6万 - 项目类别:
Control of intestinal innate immunity by the commensal microbiota in a model host
模型宿主中共生微生物群对肠道先天免疫的控制
- 批准号:
10494296 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别:
Microbiomal Mediators of TL1A-induced-Fibrosis
TL1A 诱导纤维化的微生物介质
- 批准号:
10662219 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别:
Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota
诱导 Treg 和炎症 Th17 细胞平衡响应潜在致病微生物群的决定因素
- 批准号:
10372223 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别:
T cell Tolerance to Enteric Commensal Bacteria
T 细胞对肠道共生细菌的耐受性
- 批准号:
10608196 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别:
T cell Tolerance to Enteric Commensal Bacteria
T 细胞对肠道共生细菌的耐受性
- 批准号:
10299254 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别:
Microbiomal Mediators of TL1A-induced-Fibrosis
TL1A 诱导纤维化的微生物介质
- 批准号:
10426262 - 财政年份:2021
- 资助金额:
$ 89.6万 - 项目类别: